Moat Ross bought KNSA
April 1, 2026 · Form 4 insider transaction
Moat Ross bought 36,950 shares of Kiniksa Pharmaceuticals International, plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
36,950
Price
$0.00
Total value
N/A
InsiderMoat Ross
RoleOfficer
SecurityShare Option
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after36,950
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.